466 related articles for article (PubMed ID: 26262514)
1. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
Tang A; Valasek MA; Sirlin CB
Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
[TBL] [Abstract][Full Text] [Related]
2. 2017 Version of LI-RADS for CT and MR Imaging: An Update.
Elsayes KM; Hooker JC; Agrons MM; Kielar AZ; Tang A; Fowler KJ; Chernyak V; Bashir MR; Kono Y; Do RK; Mitchell DG; Kamaya A; Hecht EM; Sirlin CB
Radiographics; 2017; 37(7):1994-2017. PubMed ID: 29131761
[TBL] [Abstract][Full Text] [Related]
3. Cirrhotic liver: What's that nodule? The LI-RADS approach.
Shah A; Tang A; Santillan C; Sirlin C
J Magn Reson Imaging; 2016 Feb; 43(2):281-94. PubMed ID: 25996905
[TBL] [Abstract][Full Text] [Related]
4. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.
Mitchell DG; Bruix J; Sherman M; Sirlin CB
Hepatology; 2015 Mar; 61(3):1056-65. PubMed ID: 25041904
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
6. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.
Tang A; Singal AG; Mitchell DG; Hecht EM; Fowler KJ; Kulik L; Parikh ND; Kono Y; Sirlin CB
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1228-1238. PubMed ID: 30326302
[TBL] [Abstract][Full Text] [Related]
7. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
8. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.
An C; Rakhmonova G; Choi JY; Kim MJ
Clin Mol Hepatol; 2016 Jun; 22(2):296-307. PubMed ID: 27304548
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
[TBL] [Abstract][Full Text] [Related]
10. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
Tang A; Bashir MR; Corwin MT; Cruite I; Dietrich CF; Do RKG; Ehman EC; Fowler KJ; Hussain HK; Jha RC; Karam AR; Mamidipalli A; Marks RM; Mitchell DG; Morgan TA; Ohliger MA; Shah A; Vu KN; Sirlin CB;
Radiology; 2018 Jan; 286(1):29-48. PubMed ID: 29166245
[TBL] [Abstract][Full Text] [Related]
11. LI-RADS v2017 for liver nodules: how we read and report.
Schima W; Heiken J
Cancer Imaging; 2018 Apr; 18(1):14. PubMed ID: 29690933
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
[TBL] [Abstract][Full Text] [Related]
13. Understanding LI-RADS: a primer for practical use.
Santillan CS; Tang A; Cruite I; Shah A; Sirlin CB
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):337-52. PubMed ID: 25086933
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.
Ludwig DR; Fraum TJ; Cannella R; Ballard DH; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
Abdom Radiol (NY); 2019 Jun; 44(6):2116-2132. PubMed ID: 30798397
[TBL] [Abstract][Full Text] [Related]
15. LI-RADS 2017: An update.
Kielar AZ; Chernyak V; Bashir MR; Do RK; Fowler KJ; Mitchell DG; Cerny M; Elsayes KM; Santillan C; Kamaya A; Kono Y; Sirlin CB; Tang A
J Magn Reson Imaging; 2018 Jun; 47(6):1459-1474. PubMed ID: 29626376
[TBL] [Abstract][Full Text] [Related]
16. LI-RADS: Past, Present, and Future, From the
Marks RM; Masch WR; Chernyak V
AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
[TBL] [Abstract][Full Text] [Related]
17. Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT.
Corwin MT; Fananapazir G; Jin M; Lamba R; Bashir MR
AJR Am J Roentgenol; 2016 Feb; 206(2):307-12. PubMed ID: 26797357
[TBL] [Abstract][Full Text] [Related]
18. Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models.
Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
J Magn Reson Imaging; 2016 Feb; 43(2):373-83. PubMed ID: 26119393
[TBL] [Abstract][Full Text] [Related]
19. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
Elsayes KM; Kielar AZ; Elmohr MM; Chernyak V; Masch WR; Furlan A; Marks RM; Cruite I; Fowler KJ; Tang A; Bashir MR; Hecht EM; Kamaya A; Jambhekar K; Kamath A; Arora S; Bijan B; Ash R; Kassam Z; Chaudhry H; McGahan JP; Yacoub JH; McInnes M; Fung AW; Shanbhogue K; Lee J; Deshmukh S; Horvat N; Mitchell DG; Do RKG; Surabhi VR; Szklaruk J; Sirlin CB
Abdom Radiol (NY); 2018 Oct; 43(10):2625-2642. PubMed ID: 30155697
[TBL] [Abstract][Full Text] [Related]
20. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.
De Gaetano AM; Catalano M; Pompili M; Marini MG; Rodríguez Carnero P; Gullì C; Infante A; Iezzi R; Ponziani FR; Cerrito L; Marrone G; Giuliante F; Ardito F; Rapaccini GL; Vecchio FM; Giraldi L; Manfredi R;
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7786-7801. PubMed ID: 31599447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
